November 6, 2018
FDA says the drug manufacturer ScieGen Pharmaceuticals has voluntarily recalled certain lots of the blood pressure therapy Irbesartan, after agency officials discovered some of the Irbesartan tablets contained an impurity believed to cause cancer.
November 5, 2018
FDA’s decision to approve a fast-acting, highly potent opioid tablet to serve as an alternative to IV painkillers typically used in hospitals is drawing concerns from some experts who say the drug could intensify the opioid misuse epidemic.
Sachin Jain, CEO of CareMore HealthSystem, argues that the United States is missing one solution "right in front of [its] eyes" when looking for ways to address the growing physician shortage.
November 2, 2018
CMS' Medicare Physician Fee Schedule final rule includes changes to evaluation and management visit payments, an initial 3% reduction in Medicare Part B payments for new drugs, new codes to expand providers' telehealth billing options, and more.
CMS has released a final rule to update Medicare's Hospital Outpatient and Ambulatory Surgical Center Payment Systems for calendar year 2019, which contains several policy updates to address payment differences between different sites of service.
November 1, 2018
HHS says a long-delayed rule that would penalize drugmakers that deliberately overcharge providers for drugs purchased under Medicare's 340B Drug Discount Program will take effect Jan. 1, 2019.
October 31, 2018
Health insurer PEHP, which covers Utah's state employees and their families, is offering enrollees a $500 cash payout, as well as covered expenses, to travel to Mexico to purchase certain prescription drugs.
October 30, 2018
Cleveland Clinic's annual list of the top 10 medical innovations that it predicts will "transform health care in 2019" includes advances in 3-D printing, artificial intelligence, and immunotherapies.
October 26, 2018
The Trump administration is considering testing an International Pricing Index model that would pilot three new initiatives intended to lower the prices of drugs covered under Medicare Part B.
Medicaid spending in 2018 rose at the same rate as 2017, despite the program experiencing its first enrollment decline since 2007, according to Kaiser Family Foundation's annual survey of state Medicaid directors.
The Advisory Board Company. All Rights Reserved.